LataMed AI Corp. (OTC: LMED) announced that Dr. Kevin Rodan, its Chief Executive Officer, is expected to receive a Certificate of Excellence from the Ministry of Health on July 10, 2026, in recognition of his contributions to healthcare innovation, technological development, clinical practice, and healthcare advancement. The recognition is part of Ministry of Health initiatives aimed at acknowledging healthcare professionals whose work supports innovation, medical technology development, and high standards of patient care.
The Company believes the recognition reflects Dr. Rodan's continued commitment to advancing healthcare accessibility, digital health innovation, and the responsible application of technology within healthcare environments. Management also believes the recognition underscores the growing importance of healthcare technology, digital infrastructure, and innovation-focused leadership in supporting the modernization of healthcare systems throughout Latin America.
Dr. Kevin Rodan stated: 'I am honored to be recognized in connection with healthcare innovation and excellence. Healthcare systems throughout Latin America continue to face significant accessibility, coordination, and infrastructure challenges, and I believe technology can play an important role in helping address those challenges. This recognition is meaningful not only personally, but also because it reflects the broader importance of innovation, collaboration, and patient-focused healthcare development.'
The Certificate of Excellence is expected to be presented during an upcoming Ministry of Health event dedicated to recognizing contributions to healthcare advancement, innovation, and excellence within the healthcare sector. The Company noted that the recognition relates to Dr. Rodan's professional contributions and leadership within the healthcare sector and does not constitute a regulatory approval, endorsement, or certification of any specific product, service, technology, or commercial initiative of the Company.
LataMed AI Corp. is a development-stage digital health and artificial intelligence technology company focused on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. The Company's strategy centers on developing technology platforms designed to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations, with an initial regional focus on Latin America. For additional information, visit https://latamed.ai or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
